Neurofeedback training may increase brain connectivity in patients with Huntington’s disease, possibly improving behavior and movement abnormalities, say British researchers…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
A protein responsible for protecting nerve cells can become embedded in other substances in the brains of  Huntington’s patients, preventing…
Researchers have come up with a new method to study the interactions between cell components that are thought to be…
Less is known about the late stages of Huntington’s disease than about its earlier stages, particularly concerning patients enrolled in…
Researchers in England and Wales have identified a gene linked to disease progression in Huntington’s disease, shedding new light on…
A snapshot of a key brain receptor in action might advance the understanding of disease processes in Huntington’s disease and…
Researchers have created the first freely available data network — called HDNetDB — that aims to advance research into…
A factor called neurofilament light (NfL) may act as a biomarker of progression in Huntington’s disease, as blood levels of…
Voyager Therapeutics has a new candidate for the treatment of Huntington’s disease. The selected gene therapy is called VY-HTT01 and aims…
A team of researchers has discovered new insights into cell processes that have gone awry in Huntingon’s disease (HD) patients.